Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. A new drug class for the treatment of hypercholesterolemia

被引：1

作者：

Martinez de Victoria, Emilio Ortega ^{[1
,2
]}

机构：

[1] Univ Barcelona, IDIBAPS, Hosp Clin Barcelona, Serv Endocrinol & Nutr, Barcelona, Spain

[2] ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain

来源：

ENDOCRINOLOGIA DIABETES Y NUTRICION | 2017年 / 64卷 / 07期

关键词：

DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; CARDIOVASCULAR EVENTS; RISK; DISCONTINUATION; METAANALYSIS; ALIROCUMAB; RATIONALE; STATINS;

D O I：

10.1016/j.endinu.2017.04.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：341 / 344

页数：4

共 25 条

[1] Mutations in PCSK9 cause autosomal dominant hypercholesterolemia [J].

Abifadel, M ;

Varret, M ;

Rabès, JP ;

Allard, D ;

Ouguerram, K ;

Devillers, M ;

Cruaud, C ;

Benjannet, S ;

Wickham, L ;

Erlich, D ;

Derré, A ;

Villéger, L ;

Farnier, M ;

Beucler, I ;

Bruckert, E ;

Chambaz, J ;

Chanu, B ;

Lecerf, JM ;

Luc, G ;

Moulin, P ;

Weissenbach, J ;

Prat, A ;

Krempf, M ;

Junien, C ;

Seidah, NG ;

Boileau, C .

NATURE GENETICS, 2003, 34 (02) :154-156

[2]

aemps, Agencia espanola de medicamentos y productos sanitarios

[3]

[Anonymous], N ENGL J MED

[4] Inhibition of proprotein convertase subtilisin/kexin type 9 in the treatment of hypercholesterolemia [J].

Ascaso, Juan F. .

ENDOCRINOLOGIA Y NUTRICION, 2016, 63 (06) :255-257

[5] Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events A Meta-Analysis of Statin Trials [J].

Boekholdt, S. Matthijs ;

Hovingh, G. Kees ;

Mora, Samia ;

Arsenault, Benoit J. ;

Amarenco, Pierre ;

Pedersen, Terje R. ;

LaRosa, John C. ;

Waters, David D. ;

DeMicco, David A. ;

Simes, R. John ;

Keech, Antony C. ;

Colquhoun, David ;

Hitman, Graham A. ;

Betteridge, John ;

Clearfield, Michael B. ;

Downs, John R. ;

Colhoun, Helen M. ;

Gotto, Antonio M., Jr. ;

Ridker, Paul M. ;

Grundy, Scott M. ;

Kastelein, John J. P. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (05) :485-494

[6]

CatSalut, SERV CAT SAL

[7] Interpretation of the evidence for the efficacy and safety of statin therapy [J].

Collins, Rory ;

Reith, Christina ;

Emberson, Jonathan ;

Armitage, Jane ;

Baigent, Colin ;

Blackwell, Lisa ;

Blumenthal, Roger ;

Danesh, John ;

Smith, George Davey ;

DeMets, David ;

Evans, Stephen ;

Law, Malcolm ;

MacMahon, Stephen ;

Martin, Seth ;

Neal, Bruce ;

Poulter, Neil ;

Preiss, David ;

Ridker, Paul ;

Roberts, Ian ;

Rodgers, Anthony ;

Sandercock, Peter ;

Schulz, Kenneth ;

Sever, Peter ;

Simes, John ;

Smeeth, Liam ;

Wald, Nicholas ;

Yusuf, Salim ;

Peto, Richard .

LANCET, 2016, 388 (10059) :2532-2561

[8] Effect of Naturally Random Allocation to Lower Low-Density Lipoprotein Cholesterol on the Risk of Coronary Heart Disease Mediated by Polymorphisms in NPC1L1, HMGCR, or Both [J].

Ference, Brian A. ;

Majeed, Faisal ;

Penumetcha, Raju ;

Flack, John M. ;

Brook, Robert D. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (15) :1552-1561

[9] Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapyA cognitive study of patients enrolled in the FOURIER trial [J].

Giugliano, Robert P. ;

Mach, Francois ;

Zavitz, Kenton ;

Kurtz, Christopher ;

Schneider, Jingjing ;

Wang, Huei ;

Keech, Anthony ;

Pedersen, Terje R. ;

Sabatine, Marc S. ;

Sever, Peter S. ;

Honarpour, Narimon ;

Wasserman, Scott M. ;

Ott, Brian R. .

CLINICAL CARDIOLOGY, 2017, 40 (02) :59-65

[10] Cardiovascular Health in a Southern Mediterranean European Country A Nationwide Population-Based Study [J].

Graciani, Auxiliadora ;

Leon-Munoz, Luz M. ;

Guallar-Castillon, Pilar ;

Rodriguez-Artalejo, Fernando ;

Banegas, Jose R. .

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (01) :90-98

← 1 2 3 →